Knight Therapeutics Inc.
KHTRF
$6.59
$0.111.70%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.47M | 6.35M | -2.75M | -9.12M | 1.52M |
| Total Depreciation and Amortization | 11.64M | 10.11M | 12.90M | 8.77M | 8.07M |
| Total Amortization of Deferred Charges | -- | 705.10K | -- | -- | -- |
| Total Other Non-Cash Items | 2.26M | -631.90K | 5.50M | 5.60M | 995.00K |
| Change in Net Operating Assets | 5.89M | 8.48M | -8.27M | 9.39M | -8.03M |
| Cash from Operations | 29.26M | 25.01M | 7.38M | 14.64M | 2.56M |
| Capital Expenditure | -2.39M | -362.20K | -297.70K | -448.10K | -259.90K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | -- | -- | 20.90K |
| Cash Acquisitions | -- | 0.00 | -2.32M | -77.25M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.93M | -2.93M | 1.60M | 4.49M | 22.62M |
| Cash from Investing | 7.54M | -3.29M | -1.02M | -73.21M | 22.38M |
| Total Debt Issued | -- | 867.00K | -- | 109.39M | 1.81M |
| Total Debt Repaid | -12.54M | -29.85M | -5.01M | -55.88M | -2.71M |
| Issuance of Common Stock | 112.00K | 133.00K | 126.00K | 363.00K | 114.00K |
| Repurchase of Common Stock | -8.24M | -3.00M | -- | -6.00K | -3.35M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -649.00K | -2.95M | -1.03M | -3.06M | -569.00K |
| Cash from Financing | -15.32M | -24.96M | -4.29M | 36.73M | -3.27M |
| Foreign Exchange rate Adjustments | 1.25M | -657.80K | 880.00K | -2.97M | 663.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.72M | -3.89M | 2.95M | -24.82M | 22.33M |